Genetic determinants of diabetic nephropathy

Clinical Science

Volumn 96, Issue 3, 1999, Pages 221-230

  Chowdhury, Tahseen A ^a   Dyer, Philip H ^a   Kumar, Sudhesh ^a   Barnett, Anthony H ^a   Bain, Stephen C ^a  

^a BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

Author keywords

Diabetes mellitus; Genetics; Nephropathy

Indexed keywords

ALDEHYDE REDUCTASE; APOLIPOPROTEIN E; HEPARAN SULFATE;

ANIMAL MODEL; CARDIOVASCULAR RISK; CHROMOSOME 12; CHROMOSOME 20; CHROMOSOME 3; CHROMOSOME 7; DIABETES MELLITUS; DIABETIC NEPHROPATHY; ETHNIC DIFFERENCE; FAMILIAL DISEASE; GENE LOCUS; GENETIC RISK; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; KIDNEY FAILURE; MULTIFACTORIAL INHERITANCE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEINURIA; RAT; REVIEW; SIBLING;

EID: 0032990386     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0960221     Document Type: Review

References (87)

1. 1 Borch-Johnsen, K., Andersen, P. K. and Deckert, T. (1985) The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 28, 590-596
2. 2 Parving, H. H. and Hommel, E. (1989) Prognosis in diabetic nephropathy. Br. Med. J. 299, 230-233
3. 3 Mogensen, C. E. (1997) How to protect the kidney in diabetic patients: with special reference to IDDM. Diabetes 46 (Suppl. 2), S104-S111
4. 4 Richards, N. T., Greaves, I., Lee, S. J., Howie, A. J., Adu, D. and Michael, J. (1992) Increased prevalence of renal biopsy findings other than diabetic glomerulopathy in type II diabetes mellitus. Nephrol. Dial. Transplant. 7, 397-399
5. 5 Anderson, A. R., Christiansen, J. S., Anderson, J. K., Kreiner, S. and Deckert, T. (1983) Diabetic nephropathy in type I (insulin-dependent) diabetes: an epidemiological study. Diabetologia 25, 496-501
6. 6 Krolewski, A. S., Warram, J. H., Christlieb, A. R., Busick, E. J. and Kahn, C. R. (1985) The changing natural history of nephropathy in type 1 diabetes. Am. J. Med. 78, 785-793
7. 7 Klein, R., Klein, B. E., Moss, S. E., Davis, M. D. and DeMets, D. L. (1984) The Wisconsin epidemiologic study of diabetic retinopathy: II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch. Ophthalmol. 102, 520-526
8. 8 Burden, A. C., McNally, P. G., Feehally, J. and Walls, J. (1992) Increased incidence of end-stage renal failure secondary to diabetes mellitus in Asian ethnic groups in the United Kingdom. Diabet. Med. 9, 641-645
9. 9 Cowie, C. C., Port, F. K., Wolfe, R. A., Savage, P. J., Moll, P. P. and Hawthorne, V. M. (1989) Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. N. Engl. J. Med. 321, 1074-1079
10. 10 Haffner, S. M., Mitchell, B. D., Pugh, J. A. et al. (1986) Proteinuria in Mexican-Americans and non-Hispanic whites with NIDDM. Diabetes Care 12, 530-536
11. 11 Collins, V. R., Dowse, G. K., Finch, C. F., Zimmet, P. Z. and Linnanae, A. W. (1989) Prevalence and risk factors for micro-and macroalbuminuria in diabetic subjects and entire population of Nauru. Diabetes 38, 1602-1610
12. 12 Pettitt, D. J., Saad, M. F., Bennett, P. H., Nelson, R. G. and Knowler, W. C. (1990) Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 33, 438-443
13. 13 Seaquist, E. R., Goetz, F. C., Rich, S. and Barbosa, J. (1989) Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N. Engl. J. Med. 320, 1161-1165
14. 14 Borch-Johnsen, K., Norgaard, K., Hommel, E. et al. (1992) Is diabetic nephropathy an inherited complication? Kidney Int. 41, 719-722
15. 15 Quinn, M., Angelico, M. C., Warram, J. H. and Krolewski, A. S. (1996) Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 39, 940-945
16. 16 The Diabetes Control and Complications Trial Research Group. (1997) Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. Diabetes 46, 1829-1839
17. 17 Faronato, P. P., Maioli, M., Tonolo, G. et al. (1997) Clustering of albumin excretion rate abnormalities in Caucasian patients with NIDDM. Diabetologia 40, 816-823
18. 18 Viberti, G. C., Keen, H. and Wiseman, M. J. (1987) Raised arterial pressure in parents of proteinuric insulin-dependent diabetics. Br. Med. J. 295, 515-518
19. 19 Krolewski, A. S., Canessa, H., Warram, J. H. et al. (1988) Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N. Engl. J. Med. 318, 140-145
20. 20 Barzilay, J., Warram, J. H., Bak, M., Laffel, L. M., Canessa, M. and Krolewski, A. S. (1992) Predisposition to hypertension: risk factor for nephropathy and hypertension in IDDM. Kidney Int. 41, 723-730
21. 21 Canessa, M., Adragna, N., Solomon, H. S., Connolly, M. and Tosteson, D. C. (1980) Increased sodium-lithium countertransport in red cells of patients with essential hypertension. N. Engl. J. Med. 302, 772-775
22. 22 Mangili, R., Bending, J. J., Scott, G., Li, L. K., Gupta, A. and Viberti, G. C. (1988) Increased sodium-lithium countertransport activity in red cells of patients with insulin-dependent diabetes and nephropathy. N. Engl. J. Med. 318, 146-149
23. 23 Walker, J. D., Tariq, T. and Viberti, G. (1990) Sodium-lithium countertransport activity in red cells of patients with insulin dependent diabetes and nephropathy and their parents. Br. Med. J. 301, 635-638
24. 24 Trevisan, R. and Viberti, G. (1997) Sodium-hydrogen antiporter: its possible role in the genesis of diabetic nephropathy. Nephrol. Dial. Transplant. 12, 643-645
25. 25 Roglic, G., Colhoun, H. M., Stevens, L. K., Lemkes, H. H., Manes, C. and Fuller, J. H. (1998) Parental history of hypertension and parental history of diabetes and microvascular complications in insulin-dependent diabetes mellitus: the EURODIAB IDDM Complications Study. Diabet. Med. 15, 418-426
26. 26 Earle, K., Walker, J., Hill, C. and Viberti, G. (1992) Familial clustering of cardiovascular disease in patients with insulin-dependent diabetes and nephropathy. N. Engl. J. Med. 326, 673-677
27. 27 De Cosmo, S., Bacci, S., Piras, G. P. et al. (1997) High prevalence of risk factors for cardiovascular disease in parents of IDDM patients with albuminuria. Diabetologia 40, 1191-1196
28. 28 Groop, L., Ekstrand, A., Forsblom, C. et al. (1993) Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 36, 642-647
29. 29 Yip, J., Mattock, M. B., Morocutti, A., Sethi, M., Trevisan, R. and Viberti, G. (1993) Insulin resistance in insulin-dependent diabetic patients with microalbuminuria. Lancet 342, 883-887
30. 30 Yip, J., Mattock, M., Sethi, M., Morocutti, A. and Viberti, G. (1993) Insulin resistance in family members of insulin-dependent diabetic patients with microalbuminuria [Letter]. Lancet 341, 369-370
31. 31 Forsblom, C. M., Eriksson, J. G., Ekstrand, A. V., Teppo, A. M., Taskinen, M. R. and Groop, L. C. (1995) Insulin resistance and abnormal albumin excretion in non-diabetic first degree relatives of patients with NIDDM. Diabetologia 38, 363-369
32. 32 Brown, D. M., Provoost, A. P., Daly, M. J., Lander, E. S. and Jacob, H. J. (1996) Renal disease susceptibility and hypertension are under independent genetic control in the fawn-hooded rat. Nature Gen. 12, 44-51
33. 33 Altshuler, D., Kruglyak, L. and Lander, E. (1998) Genetic polymorphisms and disease (Letter). N. Engl. J. Med. 338, 1626
34. 34 Spielman, R. S., McGinnis, R. E. and Ewens, W. J. (1993) Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am. J. Hum. Genet. 52, 506-516
35. 35 Davies, J. L., Kawaguchi, Y., Bennett, S. T. et al. (1994) A genome-wide search for human type 1 diabetes susceptibility genes. Nature (London) 371, 130-136
36. 36 Moczulski, D. K., Rogus, J. J., Antonellis, A., Warram, J. H. and Krolewski, A. S. (1998) Major susceptibility locus for nephropathy in type 1 diabetes on chromosome 3q. Results of a novel discordant sib-pair analysis. Diabetes 47, 1164-1169
37. 37 Pyke, D. and Tattersall, R. (1973) Diabetic retinopathy in identical twins. Diabetes 22, 613-618
38. 38 Barbosa, J., Cohen, R. A., Chavers, B. et al. (1980) Muscle extracellular membrane immunofluorescence and HLA as possible markers of prediabetes. Lancet ii, 330-333
39. 39 Barbosa, J. and Saner, B. (1984) Do genetic factors play a role in the pathogenesis of diabetic microangiopathy? Diabetologia 27, 487-492
40. 40 Chowdhury, T. A., Dyer, P. H., Barnett, A. H. and Bain, S. C. (1998) HLA and insulin (INS) genes Caucasians with type 1 diabetes and nephropathy (Abstract). Diabetologia 41 (Suppl. 1), A296
41. 41 Mandrup-Poulsen, T., Owerbach, D., Mortensen, S. A. et al. (1984) DNA sequences flanking the insulin gene on chromosome 11 confer risk of atherosclerosis. Lancet i, 250-252
42. 42 Raffel, L. J., Vadheim, C. M., Roth, M.-P., Klein, R., Moss, S. E. and Rotter, J. I. (1991) The 5′ insulin gene polymorphism and the genetics of vascular complications in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 34, 680-683
43. 43 Hallab, M., Bled, F. and Ebran, J. M. (1992) Elevated serum angiotensin converting enzyme activity in type 1, insulin dependent diabetic subjects with persistent microalbuminuria. Acta Diabetol. 29, 82-85
44. 44 Rigat, B., Hubert, C., Alhenc-Gelas, F., Cambien, F., Corvol, P. and Soubrier, F. (1990) An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. 86, 1343-1346
45. 45 Doria, A., Warram, J. H. and Krolewski, A. S. (1994) Genetic predisposition to diabetic nephropathy. Evidence for a role of the angiotensin I-converting enzyme gene. Diabetes 43, 690-695
46. 46 Marre, M., Bernadet, P., Gallois, Y. et al. (1994) Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 43, 384-388
47. 47 Schmidt, S., Schone, N. and Ritz, E. (1995) Association of ACE gene polymorphism and diabetic nephropathy? The Diabetic Nephropathy Study Group. Kidney Int. 47, 1176-1181
48. 48 Tarnow, L., Cambien, F., Rossing, P. et al. (1995) Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes 44, 489-494
49. 49 Chowdhury, T. A., Dronsfield, M. J., Kumar, S. et al. (1996) Examination of two genetic polymorphisms within the renin-angiotensin system: no evidence for an association with nephropathy in IDDM. Diabetologia 39, 1108-1114
50. 50 Fujisawa, T., Ikegami, H., Kawaguchi, Y. et al. (1998) Meta-analysis of association of insertion/deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy. Diabetologia 41, 47-53
51. 51 Tarnow, L., Cambien, F., Rossing, P. et al. (1995) Insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy. Diabetologia 38, 798-803
52. 52 Parving, H. H., Jacobsen, P., Tarnow, L. et al. (1996) Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study. Br. Med. J. 313, 591-594
53. 53 Penno, G., Chaturvedi, N., Talmud, P. J. et al. (1998) Effect of angiotensin-converting enzyme (ACE) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients. Diabetes 47, 1507-1511
54. 54 van Essen, G. G., Rensma, P. L., de Zeeuw, D. et al. (1996) Association between angiotensin-converting-enzyme gene polymorphism and failure of renoprotective therapy. Lancet 347, 94-95
55. 55 Caulfield, M., Lavender, P., Farrall, M. et al. (1994) Linkage of the angiotensinogen gene to essential hypertension. N. Engl. J. Med. 330, 1629-1633
56. 56 Fogarty, D. G., Harron, J. C., Hughes, A. E., Nevin, N. C., Doherty, C. C. and Maxwell, A. P. (1996) A molecular variant of angiotensinogen is associated with diabetic nephropathy in IDDM. Diabetes 45, 1204-1208
57. 57 Schmidt, S., Giessel, R., Bergis, K. H. et al. (1996) Angiotensinogen gene M235T polymorphism is not associated with diabetic nephropathy. The Diabetic Nephropathy Study Group. Nephrol. Dial. Transplant. 11, 1755-1761
58. 58 Tarnow, L., Cambien, F., Rossing, P. et al. (1996) Angiotensinogen gene polymorphisms in IDDM patients with diabetic nephropathy. Diabetes 45, 367-369
59. 59 Bonnardeaux, A., Davies, E., Jeunemaitre, X. et al. (1994) Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 24, 63-69
60. 60 Chowdhury, T. A., Dyer, P. H., Kumar, S. et al. (1997) Lack of association of angiotensin II type 1 receptor gene polymorphism with diabetic nephropathy in insulin-dependent diabetes mellitus. Diabetic Med. 14, 837-840
61. 61 Tarnow, L., Cambien, F., Rossing, P. et al. (1996) Angiotensin-II type 1 receptor gene polymorphism and diabetic microangiopathy. Nephrol. Dial. Transplant. 11, 1019-1023
62. 62 Doria, A., Onuma, T., Warram, J. H. and Krolewski, A. S. (1997) Synergistic effect of angiotensin II type 1 receptor genotype and poor glycaemic control on risk of nephropathy in IDDM. Diabetologia 40, 1293-1299
63. 63 Heesom, A. E., Hibberd, M. L., Millward, A. and Demaine, A. G. (1997) Polymorphism in the 5′-end of the aldose reductase gene is strongly associated with the development of diabetic nephropathy in type I diabetes. Diabetes 46, 287-291
64. 63a Dyer, P. H., Chowdhury, T. A., Barnett, A. H. and Bain, S. C. Aldose reductase gene polymorphism and nephropathy in Type I diabetes (Letter). Diabetologia, in the press.
65. 64 Moczulski, D. K., Burak, W., Zynchma, M., Szczechowska, E. Z., Warram, J. H. and Grzeszczak, W. (1998) Role of aldose reductase gene in susceptibility to diabetic nephropathy in NIDDM (Abstract). Diabetes 47 (Suppl. 1), A52
66. 65 Deckert, T., Feldt Rasmussen, B., Borch-Johnsen, K., Jensen, T. and Kofoed-Enevoldsen, A. (1989) Albuminuria reflects widespread vascular damage. The Steno Hypothesis. Diabetologia 32, 219-226
67. 66 Hansen, P. M., Chowdhury, T., Deckert, T., Hellgren, A., Bain, S. C. and Pociot, F. (1997) Genetic variation of the heparan sulfate proteoglycan gene (perlecan gene). Association with urinary albumin excretion in IDDM patients. Diabetes 46, 1658-1659
68. 67 Chen, J. W., Hansen, P. M., Tarnow, L., Hellgren, A., Deckert, T. and Pociot, F. (1997) Genetic variation of a collagen IV alpha 1-chain gene polymorphism in Danish insulin-dependent diabetes mellitus (IDDM) patients: lack of association to nephropathy and proliferative retinopathy. Diabetic Med. 14, 143-147
69. 68 Chowdhury, T. A., Dyer, P. H., Kumar, S. et al. (1998) Association of apolipoprotein epsilon2 allele with diabetic nephropathy in Caucasian subjects with IDDM. Diabetes 47, 278-280
70. 69 Lam, K. S. L., Cheng, I. K. P., Janus, E. D. and Pang, R. W. C. (1995) Cholesterol-lowering therapy may retard the progression of diabetic nephropathy. Diabetologia 38, 604-609
71. 70 Werle, E., Fiehn, W. and Hasslacher, C. (1998) Apolipoprotein E polymorphism and renal function in German type 1 and type 2 diabetic patients. Diabetes Care 21, 994-998
72. 71 Araki, S. C., Zanchi, A., Moczulski, D. K., Wantman, M. and Krolewski, A. S. (1998) ApoE e2 allele increases the risk of diabetic nephropathy (DN) in IDDM: results of a family based study (Abstract). Diabetes 47 (Suppl. 1), A76
73. 72 Blakemore, A. I. F., Cox, A., Gonzalez, A. M. et al. (1996) Interleukin-1 receptor antagonist allele (IL1RN*2) associated with nephropathy in diabetes mellitus. Hum. Genet. 97, 369-374
74. 73 Tarnow, L., Pociot, F., Hansen, P. M. et al. (1997) Polymorphisms in the interleukin-1 gene cluster do not contribute to the genetic susceptibility of diabetic nephropathy in Caucasian patients with IDDM. Diabetes 46, 1075-1076
75. 74 Colhoun, H., Senee, V., Chaturvedi, N., Julier, C. and Fuller, J. (1998) Association of TGF-β1 gene with albumin excretion rate progression and effect of lisinopril treatment in the EUCLID study. Diabetes 47 (Suppl. 1), A394
76. 75 Grzeszczak, W., Saucha, W., Zychma, M. and Zuckowska-Szczechowska, E. (1998) Association of a polymorphism in the β3 adrenergic receptor gene with development of nephropathy in NIDDM subjects (Abstract). Diabetologia 41 (Suppl. 1), A295
77. 76 Scaglione, I., Gambino, R., Lillaz, E., Cassader, M., Pagano, G. and Cavallo-Perin, P. (1998) PLA polymorphism of the platelet glycoprotein IIIA is not associated with diabetic nephropathy in NIDDM patients (Abstract). Diabetologia 41 (Suppl. 1), A295
78. 77 Schmidt, S. and Ritz, E. (1997) Genetic determinants of diabetic renal disease and their impact on therapeutic interventions. Kidney Int. 52 (Suppl. 63), S27-S31
79. 78 Zanchi, A., Wantman, M., Moczulski, D. K. and Warram, J. H. (1998) Genetic susceptibility to diabetic nephropathy in IDDM is related to polymorphism in the endothelial nitric oxide synthase (eNOS) gene (Abstract). Diabetes 47 (Suppl. 1), A52
80. 79 Mlynarska, A., Witas, H. W., Mlynarski, R. et al. (1998) PAI-1 gene polymorphism may be involved in retinopathy and microalbuminuria in children with type 1 diabetes (Abstract). Diabetologia 41 (Suppl. 1), A295
81. 80 Neugebauer, S., Baba, T. and Watanabe, T. (1998) Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy in NIDDM patients (Letter). Lancet 352, 454
82. 81 Morita, H., Taguchi, J. I. and Kurihara, H. (1997) Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. Circulation 95, 2032-2036
83. 82 Harrison, P. J. and Geddes, J. R. (1996) Schizophrenia and the 5-HT2A receptor gene. Lancet 347, 1274
84. 83 Yu, H., Bowden, D. W., Spray, B. J., Rich, S. S. and Freedman, B. I. (1996) Linkage analysis between loci in the renin-angiotensin axis and end-stage renal disease in African Americans. J. Am. Soc. Nephrol. 7, 2559-2564
85. 84 Bowden, D. W., Sale, M., Howard, T. D. et al. (1997) Linkage of genetic markers on human chromosomes 20 and 12 to NIDDM in Caucasian sib pairs with a history of diabetic nephropathy. Diabetes 46, 882-886
86. 85 Imperatore, G., Hanson, R. L., Pettitt, D. J., Kobes, S., Bennett, P. H. and Knowler, W. C. (1998) Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Diabetes 47, 821-830
87. 86 Rogus, J. J., Moczulski, D., Freire, M. B. S., Yang, Y., Warram, J. H. and Krolewski, A. S. (1998) Diabetic nephropathy is associated with AGT polymorphism T235. Results of a family-based study. Hypertension 31, 627-631